Yintao Li

9PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2026
The Role of Noncoding RNA in MGMT-Positive Glioblastoma: A Narrative Review.

|Aug 13, 2026
Beyond the P Value: A Systematic Framework for Interpreting Oncology Clinical Trials.

|Jun 27, 2026
Real-world comparison of chemoimmunotherapy and chemotherapy alone in elderly patients (≥75 years) with extensive-stage small cell lung Cancer.

|Jun 01, 2026
Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial.

|Nov 27, 2025
Efficacy of Almonertinib Versus Osimertinib as the First-Line Treatment for Non-Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study.

Xiujing Yao, Ruyue Li, Xue Dong

|Apr 18, 2025
Nomogram based on computed tomography radiomics features and clinicopathological factors to predict the prognosis of patients with non-small cell lung cancer receiving immune checkpoint inhibitor rechallenge.

Junfeng Zhao, Ying Li, Ruyue Li

Pageof 2

Frequent Collaborators

3 joint publications

Junfeng Zhao

2 joint publications

Ying Li

1 joint publications

Ruyue Li

1 joint publications

Huanle Zhang